SCHEMBL6967987

SCHEMBL6967987

O=C1NC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
CHRM3 P20309 6/20 0.39
MGLL Q99685 5/20 0.39
CYP2C9 P11712 2/20 0.38
CACNA1F O60840 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTR2A P28223 1/20 0.38
HRH1 P35367 1/20 0.38
SCN1A P35498 1/20 0.38
SCN4A P35499 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
CACNA1D Q01668 1/20 0.38
KCNH2 Q12809 1/20 0.38
CACNA1S Q13698 1/20 0.38
CACNA1C Q13936 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1438989 0.77 MMP2 (0.40) MGLLCYP2C9CACNA1FALDH1A1MAPT
SCHEMBL1438983 0.77 MMP2 (0.40) MGLLCYP2C9CACNA1FALDH1A1MAPT
SCHEMBL14846663 0.77 MMP2 (0.40) MGLLCYP2C9CACNA1FALDH1A1MAPT
SCHEMBL7211090 0.73 GAA (0.39) MGLLCYP2C9CACNA1FALDH1A1MAPT
SCHEMBL3724373 0.70 BACE1 (0.46) CHRM3CYP2C9CACNA1FALDH1A1MAPT
SCHEMBL3613976 0.70 GAA (0.37) CHRM3MGLLCYP2C9CACNA1FALDH1A1
SCHEMBL6376781 0.68 MGLL (0.36) MGLLCYP2C9CACNA1FALDH1A1MAPT
SCHEMBL29090570 0.67 NPY5R (0.36) HTR2AKCNH2NPY5RMEN1KMT2A
SCHEMBL7846201 0.66 HTR1A (0.37) HDAC3HDAC2HDAC8NCOR2CYP2C9
SCHEMBL6809751 0.66 S1PR1 (0.40) CHRM3MGLLCYP2C9ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed
US-4009039-A Heat developable light-sensitive oxazoline containing element FUJI PHOTO FILM CO., LTD. (JA) 1977-02-22 US disclosed